Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jul;10(13):4344-4355.
doi: 10.1002/cam4.3980. Epub 2021 May 31.

A nomogram to predict the cancer-specific survival of stage II-IV Epithelial ovarian cancer after bulking surgery and chemotherapy

Affiliations

A nomogram to predict the cancer-specific survival of stage II-IV Epithelial ovarian cancer after bulking surgery and chemotherapy

Ling Zhao et al. Cancer Med. 2021 Jul.

Abstract

Objective: In order to predict the survival rate of ovarian cancer patients, multiple independent risk factors are integrated to establish a prognostic nomogram.

Methods: Cox analysis was used to construct the nomogram. All of the mainly independent factors, which can be used to predict 3-year and 5-year survival rates for cancer in the training cohort, were incorporated to establish nomograms. The C-index, operating characteristic, ROC curves, and calibration plots can show evaluation results of performance.

Results: Model derivation was based on 3277 patients who belong to different races. The best threshold for age was 51, 59, and 67 year old and the older the people, the worse their survival. Meanwhile, many lymph node examinations indicated a favorable survival and the survival of the positive set was worse than of that. In addition, the optional threshold was 64 mm for tumor size and the set larger than 64 mm had a better survival than that less than 64 mm. Univariate Cox proportional hazards regression model showed that the similar worse outcomes were showed in black race, advanced grade, stage T3, stage M1, lymph nodes positive, and CA125 positive compared with the first group. We found that the number of lymph nodes examined and tumor size had an inverse relationship with its corresponding score of CSS in training cases with bulking surgery and chemotherapy.

Conclusions: We developed a model which relatively accurately predicted the prognosis of ovarian cancer by multiple univariate analysis, at the same time, the proposed nomograms exhibit superior prognostic discrimination and survival prediction.

Keywords: SEER; nomogram; ovarian cancer; prognosis; surgical therapy; survival.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflict of interest to declare.

Figures

FIGURE 1
FIGURE 1
Data selection flowchart
FIGURE 2
FIGURE 2
Identification of optimal cut‐off values of age (A, B), lymph nodes examined (C, D), lymph nodes positive (E, F) and tumor size (G, H) via X‐tile software analysis. Age could be divided into four groups: <52 years old, 52–59 years old, 60–67 years old, and ≥68 years old; the critical group for lymph nodes examined were 1–3 nodes, 4–9 nodes, 10–19 nodes, and ≥20 nodes; lymph nodes positive were divided into two categories, namely negative and positive; and the threshold in tumor size was 64 mm
FIGURE 3
FIGURE 3
Nomograms to predict 3‐ and 5‐year cancer‐specific survival for patients with epithelial ovarian cancer after bulking surgery and chemotherapy
FIGURE 4
FIGURE 4
The calibration plot established for the nomogram in the training cohort and test cohort. x‐axis described nomogram‐predicted survival; y‐axis indicated observation survival. The graph along the 45‐degree line showed the ideal calibration model, where the predicted probability was consistent with the actual result. The two pictures above are the modeling group, and the two pictures below are the verification group
FIGURE 5
FIGURE 5
Kaplan–Meier survival curves of stratified risk groups in the training group, test group, and the whole cases. The risk scores were divided into four groups: 142.5–368.5 points, 368.6–392.6 points, 392.7–411.5 points, and >411.5 points

Similar articles

Cited by

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7‐34. - PubMed
    1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394‐424. - PubMed
    1. Torre LA, Trabert B, DeSantis CE, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284‐296. - PMC - PubMed
    1. Vogel TJ, Jeon C, Karlan B, Walsh C. Digoxin therapy is not associated with improved survival in epithelial ovarian cancer: a SEER‐Medicare database analysis. Gynecol Oncol. 2016;140(2):285‐288. - PubMed
    1. Doll KM, Pinheiro LC, Reeve BB. Pre‐diagnosis health‐related quality of life, surgery, and survival in women with advanced epithelial ovarian cancer: a SEER‐MHOS study. Gynecol Oncol. 2017;144(2):348‐353. - PMC - PubMed

MeSH terms